- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AZNCF
Recent news which mentions AZNCF
AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
October 20, 2021
From Benzinga
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
From Benzinga
From Benzinga
EMA's Risk Assessment Committee Finds Link Of Rare Cases Between JNJ COVID-19 Shot, Blood Clots
October 01, 2021
From Benzinga
AstraZeneca COVID-19 Jab Shows 74% Efficacy In US Trial
September 30, 2021
From Benzinga
Adagio's COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
September 29, 2021
From Benzinga
AstraZeneca Buys Fortress-Biotech Founded Caelum For $500M
September 29, 2021
From Benzinga
AstraZeneca's Saphnelo For Lupus Treatment Approved In Japan
September 28, 2021
From Benzinga
AstraZeneca, Sputnik Light COVID-19 Vaccine Mix Shows Strong Antibody Growth: Reuters
September 27, 2021
From Benzinga
AstraZeneca - Merck's Lynparza Delays Disease Progression In Prostate Cancer Patients
September 24, 2021
From Benzinga
AstraZeneca Invests In Imperial College's Self-Amplifying RNA Tech
September 23, 2021
From Benzinga
AstraZeneca To Inject $360M In Irish API Manufacturing Site
September 21, 2021
From Benzinga
AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer Trials
September 20, 2021
From Benzinga
AstraZeneca Touts Longest Survival Update In Lung Cancer Setting With Imfinzi/Chemo Data
September 20, 2021
From Benzinga
AstraZeneca's Imfinzi / Tremelimumab Combo Regime Shows Survival Benefit In Lung Cancer Settings
September 09, 2021
From Benzinga
Amgen, AstraZeneca Tout Additional Data From Asthma Trial With Tezepelumab
September 07, 2021
From Benzinga
Why Innate Pharma Shares Are Rising On Friday?
September 03, 2021
From Benzinga
AstraZeneca's Ultomiris Scores European Nod For Rare Blood Disorder In Kids, Adolescents
September 03, 2021
From Benzinga
AstraZeneca, EU Reach Settlement On COVID-19 Vaccine Delivery
September 03, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Britain Study Shows Restricted Use Of AstraZeneca COVID-19 Shot Associated With No Clot Cases: Reuters
August 12, 2021
From Benzinga
From Benzinga
AstraZeneca' Saphnelo Wins FDA Nod For Systemic Lupus Erythematosus, Marking New Treatment Approval In 10 Years
August 02, 2021
From Benzinga
From Benzinga
AstraZeneca Stock Gains As Q2 Earnings Beat Forecasts, Clocks $894M In COVID-19 Vaccine Sales
July 29, 2021
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.